Haemonetics (NYSE:HAE) reported earnings of $0.43 per share meeting Walls Streets expectations.

ME Staff
-
0

Haemonetics (NYSE:HAE) reported Q4 2018 earnings this Morning, coming in at $0.43 per share, in-line Wall Street’s estimates of $0.43 per Share. Revenue for the quarter came in at $233.55 million beating analyst estimates of $226.63 million

Recent Insider Trading for Haemonetics (NYSE:HAE)

  • On 4/6/2018 Dan Goldstein, VP, sold 518 with an average share price of $54.65 per share and the total transaction amounting to $28,308.70.
  • On 3/6/2018 Jacqueline Scanlan, SVP, sold 114 with an average share price of $72.23 per share and the total transaction amounting to $8,234.22.
  • On 3/6/2018 Michelle L. Basil, EVP, sold 389 with an average share price of $72.23 per share and the total transaction amounting to $28,097.47.
  • On 1/2/2018 Mark W Kroll, Director, sold 7,118 with an average share price of $63.00 per share and the total transaction amounting to $448,434.00.
  • On 12/1/2017 Pedro P Granadillo, Director, sold 7,118 with an average share price of $57.06 per share and the total transaction amounting to $406,153.08.
  • On 11/16/2017 Ronald G Gelbman, Director, sold 5,440 with an average share price of $56.69 per share and the total transaction amounting to $308,393.60.



Dividend History for Haemonetics (NYSE:HAE)



    Recent Trading for Haemonetics (NYSE:HAE)
    Shares of Haemonetics closed the previous trading session at 78.03 +0.00 0.00% with shares trading hands.